fda compounding glp-1 enforcement news The FDA's Crackdown Continues: What to Know National Minority Quality Forum Launches

In view of patient safety and preserve the science-based drug approval pathway, the FDA has issued a significant proposal regarding popular GLP-1 medications

Patients with T2DM and a high cardiovascular risk might reduce their risk of atherosclerotic events via the use of GLP-1RA ( Many physicians and researchers have become interested in the potential cardiovascular advantages of GLP-1 and GLP-1-based medication since the discovery of GLP-1Rs on cardiomyocytes

Since you want to shut things down quickly, I prefer a prescription retinoid first, says Munavalli

Scientific References Ozempic | European Medicines Agency (EMA)